News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
HALE DAVID F
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/30/2023 |
4
| HALE DAVID F (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 37,500 options
@ $0.3553, valued at
$13.3k
|
|
| 03/31/2023 |
SC 13D/A
| HALE DAVID F reports a 1.9% stake in Dermata Therapeutics, Inc. |
| 10/07/2022 |
4
| HALE DAVID F (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 30,155 shares
@ $0 |
|
| 07/08/2022 |
4
| HALE DAVID F (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 26,441 shares
@ $0 |
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2022 |
4
| HALE DAVID F (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 15,466 shares
@ $0 |
|
| 02/11/2022 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| HALE DAVID F (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 5,000 options to buy
@ $1.88, valued at
$9.4k
|
|
| 12/10/2021 |
4
| HALE DAVID F (Director) has filed a Form 4 on BIOCEPT INC|
Txns:
| Sold 363 shares
@ $4.0602, valued at
$1.5k
Sold 11 shares
@ $4.0717, valued at
$44.8
Sold 71 shares
@ $4.0664, valued at
$288.7 |
|
| 08/27/2021 |
SC 13D
| HALE DAVID F reports a 7.5% stake in Dermata Therapeutics, Inc. |
| 08/17/2021 |
4
| HALE DAVID F (10% Owner) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Converted 44,777 shares
@ $0
Converted 12,195 shares
@ $0
Converted 20,000 shares
@ $0
Converted 174,216 shares
@ $0
Converted 27,103 shares
@ $0
Bought 35,714 shares
@ $0
Converted 302,112 options to buy
@ $0
Converted 250,000 options to buy
@ $0
Converted 410,000 options to buy
@ $0
Converted 3,571,428 options to buy
@ $0
Converted 555,622 options to buy
@ $0 |
|
| 08/12/2021 |
3
| HALE DAVID F (Director) has filed a Form 3 on Dermata Therapeutics, Inc. |
| 07/20/2021 |
4
| HALE DAVID F (Director) has filed a Form 4 on BIOCEPT INC|
Txns:
| Granted 10,000 options to buy
@ $3.77, valued at
$37.7k
|
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/31/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/12/2020 |
4
| HALE DAVID F (Director) has filed a Form 4 on BIOCEPT INC|
Txns:
| Sold 159 shares
@ $0.5578, valued at
$88.7
Sold 445 shares
@ $0.5545, valued at
$246.8
Sold 556 shares
@ $0.555, valued at
$308.6 |
|
| 06/12/2020 |
4
| HALE DAVID F (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 22,500 options
@ $2.94, valued at
$66.2k
|
|
| 06/09/2020 |
4
| HALE DAVID F (Director) has filed a Form 4 on BIOCEPT INC|
Txns:
| Granted 500 options to buy
@ $0.4797, valued at
$239.9 |
|
| 05/22/2020 |
4
| HALE DAVID F (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Bought 17,412 shares
@ $0
Bought 8,706 warrants
@ $2.51, valued at
$21.9k
|
|
| 09/16/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2019 |
4
| HALE DAVID F (Director) has filed a Form 4 on Conatus Pharmaceuticals Inc.|
Txns:
| Granted 45,000 options to buy
@ $0.29, valued at
$13.1k
|
|
| 06/19/2019 |
4
| HALE DAVID F (Director) has filed a Form 4 on BIOCEPT INC|
Txns:
| Granted 30,000 options to buy
@ $0.91, valued at
$27.3k
Granted 500 options to buy
@ $1.02, valued at
$510 |
|
| 06/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/02/2018 |
4
| HALE DAVID F (Director) has filed a Form 4 on BIOCEPT INC|
Txns:
| Granted 15,000 options to buy
@ $0.2, valued at
$3k
|
|
| 06/25/2018 |
4
| HALE DAVID F (Director) has filed a Form 4 on Conatus Pharmaceuticals Inc.|
Txns:
| Granted 45,000 options to buy
@ $4.99, valued at
$224.6k
|
|
| 06/26/2017 |
4
| HALE DAVID F (Director) has filed a Form 4 on Conatus Pharmaceuticals Inc.|
Txns:
| Granted 45,000 options to buy
@ $4.96, valued at
$223.2k
|
|
| 06/02/2017 |
4
| HALE DAVID F (Director) has filed a Form 4 on BIOCEPT INC|
Txns:
| Granted 15,000 options to buy
@ $1.5, valued at
$22.5k
|
|
| 04/03/2017 |
4
| HALE DAVID F (Director) has filed a Form 4 on BIOCEPT INC |
| 10/21/2016 |
4
| HALE DAVID F (Director) has filed a Form 4 on BIOCEPT INC |
| 10/21/2016 |
3/A
| HALE DAVID F (Director) has filed a Form 3/A on BIOCEPT INC |
| 05/05/2016 |
4
| HALE DAVID F (Director) has filed a Form 4 on BIOCEPT INC|
Txns:
| Bought 50,000 shares
@ $1, valued at
$50k
Bought 35,000 options to buy
@ $1.3, valued at
$45.5k
|
|
|
|
|